Evidence map›Paper›PMID 25871399›Full record

ArticleOncotarget2015

Chorein addiction in VPS13A overexpressing rhabdomyosarcoma cells.

Sabina Honisch, Willi Yu, Guilai Liu, Ioana Alesutan, Syeda T Towhid, Anna Tsapara, Sabine Schleicher, Rupert Handgretinger, Christos Stournaras, Florian Lang

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Chorein Regulates Key Osteoblast Genes in UMR-106 Cells.Cell biochemistry and biophysics · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Decreased NaScientific reports · 2020
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sabina HonischDepartment of Physiology, University of Tübingen, Tübingen, Germany.
Willi YuDepartment of Physiology, University of Tübingen, Tübingen, Germany.
Guilai LiuDepartment of Physiology, University of Tübingen, Tübingen, Germany.
Ioana AlesutanDepartment of Physiology, University of Tübingen, Tübingen, Germany.
Syeda T TowhidDepartment of Physiology, University of Tübingen, Tübingen, Germany.
Anna TsaparaDepartment of Biochemistry, University of Crete Medical School, Heraklion, Greece.
Sabine SchleicherDepartment of Hematology and Oncology, Children's Hospital, University Hospital of Tuebingen, Tübingen, Germany.
Rupert HandgretingerDepartment of Hematology and Oncology, Children's Hospital, University Hospital of Tuebingen, Tübingen, Germany.
Christos StournarasDepartment of Physiology, University of Tübingen, Tübingen, Germany.
Florian LangDepartment of Physiology, University of Tübingen, Tübingen, Germany.
University of Tübingen · DEUniversity Children's Hospital Tübingen · DEUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chorein encoded by VPS13A (vacuolar protein sorting-associated protein 13A) is defective in chorea-acanthocytosis. Chorein fosters neuronal cell survival, cortical actin polymerization and cell stiffness. In view of its anti-apoptotic effect in neurons, we explored whether chorein is expressed in cancer cells and influences cancer cell survival. RT-PCR was employed to determine transcript levels, specific siRNA to silence chorein, FACS analysis to follow apoptosis and Western blotting to quantify protein abundance. Chorein transcripts were detected in various cancer cell types. The mRNA coding for chorein and chorein protein were most abundant in drug resistant, poorly differentiated human rhabdomyosarcoma cells. Chorein silencing significantly reduced the ratio of phosphorylated (and thus activated) to total phosphoinositide 3 kinase (PI-3K), pointing to inactivation of this crucial pro-survival signaling molecule. Moreover, chorein silencing diminished transcript levels and protein expression of anti-apoptotic BCL-2 and enhanced transcript levels of pro-apoptotic Bax. Silencing of chorein in rhabdomyosarcoma cells was followed by mitochondrial depolarization, caspase 3 activation and stimulation of early and late apoptosis. In conclusion, chorein is expressed in various cancer cells. In cells with high chorein expression levels chorein silencing promotes apoptotic cell death, an effect paralleled by down-regulation of PI-3K activity and BCL-2/Bax expression ratio.

Indexed as

Caco-2 CellsChildFemaleHumansNeuroacanthocytosisRhabdomyosarcomaRNA, MessengerTransfectionTumor Cells, CulturedVesicular Transport ProteinsRNA, MessengerVesicular Transport ProteinsVPS13A protein, humanapoptosisBaxBCL-2cancerPI-3K

Identifiers

PMID25871399
PMCPMC4496357
OpenAlexW1532618849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.